Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.39
+0.43 (4.80%)
At close: Mar 9, 2026, 4:00 PM EDT
9.35
-0.04 (-0.43%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $829.42 million as of March 9, 2026. Its market cap has increased by 29.27% in one year.
Market Cap
829.42M
Enterprise Value
182.63M
1-Year Change
29.27%
Ranking
Category
Stock Price
$9.39
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $829.42M, an increase of 629.48%. That is a compound annual growth rate of 21.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 829.40M | -8.26% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 870.53M |
| MapLight Therapeutics | 863.66M |
| Arvinas | 855.16M |
| CytomX Therapeutics | 852.26M |
| Janux Therapeutics | 850.43M |
| Annexon | 833.22M |
| MannKind | 825.71M |
| BridgeBio Oncology Therapeutics | 825.14M |